Immunogenicity and protective efficacy of an inactivated SFTS vaccine candidate in mice

Immunogenicity and protective efficacy of an inactivated SFTS vaccine candidate in mice

Severe fever with thrombocytopenia syndrome (SFTS), caused by a novel identified bunyavirus SFTS virus (SFTSV), was an emerging viral infectious disease that was firstly reported in China. There are no licensed vaccines and therapeutics against SFTSV currently. B-Propiolactone (BPL) inactivated whol...

Full description

Bibliographic Details
Main Authors: Aqian Li, Xinxian Dai, Lei Chen, Lin Liu, Chuan Li, Yang Liu, Wei Wu, Xiaoxia Huang, Jiandong Li, Shiwen Wang, Mifang Liang, Xiuling Li, Dexin Li
Format: Article
Language:English
Published: Elsevier 2022-02-01
Series:Biosafety and Health
Subjects:
SFTS virus
Inactivated vaccine
Immunogenicity
Protective efficacy
Online Access:http://www.sciencedirect.com/science/article/pii/S2590053621001282

Internet

http://www.sciencedirect.com/science/article/pii/S2590053621001282

Similar Items